Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013–2023)
Matrix metalloproteinases (MMPs) are identifiable members of proteolytic enzymes that can degrade a wide range of proteins in the extracellular matrix (ECM). MMPs can be categorized into six groups based on their substrate specificity and structural differences: collagenases, gelatinases, stromelysi...
Main Authors: | Shriefa Almutairi, Hanin Moh’d Kalloush, Nour A. Manoon, Sanaa K. Bardaweel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/14/5567 |
Similar Items
-
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
by: Maryam Raeeszadeh-Sarmazdeh, et al.
Published: (2020-05-01) -
Matrix metalloproteinases in nephrotic syndrome; a vital but obscure field of research
by: Souparnika Sreelatha, et al.
Published: (2019-07-01) -
A mini review on the associations of matrix metalloproteinases (MMPs) -1, -8, -13 with periodontal disease
by: Fazle Khuda, et al.
Published: (2021-01-01) -
Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer
by: Y. Zhang, et al. -
Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice
by: Sandra Magnoni, et al.
Published: (2004-11-01)